Pharmafile Logo
Pharmafocus logo
Advanced Search

Bayer’s Nexavar and Xarelto key to future growth

pharmafile | November 9, 2007 | News story | Sales and Marketing |  Bayer, Xarelto 

Related Content

Evotec and Bayer announce new kidney disease study

Evotec and Bayer have announced the initiation of a phase 2 clinical study in kidney …

Third application for Orion’s prostate cancer drug submitted by partner Bayer

Finnish pharmaceutical company Orion has announced that its partner Bayer is applying for a third application …

Bayer and Evotec to collaborate on precision cardiology

Bayer and Evotec have announced that they have updated the focus of their collaboration to …

The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025